Focus: Globus Medical is a publicly-traded medical device company specializing in minimally-invasive surgical tools for spinal and musculoskeletal conditions. The company generated $1.6B in FY2025 revenue with a strong 60% YoY growth trajectory.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Hot — 1129 jobs added in 30d
Net +766 (1129 new, 363 removed). Aggressive expansion phase.
Best fit for medical device engineers, clinical operations specialists, and commercial professionals seeking growth-stage stability; less suitable for drug-development or research-focused careers.
Help build intelligence for Globus Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Globus Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
Cencora Launches Enhanced Nucleus Solution for Specialty Practices TradingView
LivaNova Reports Improved OSA Outcomes With PolySync Programming - TradingView
LivaNova Reports Improved OSA Outcomes With PolySync Programming TradingView
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use - TradingView
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use TradingView
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal - TradingView
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal TradingView
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Reasons to Hold HealthEquity Stock in Your Portfolio for Now TradingView
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership - TradingView
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership TradingView
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Safety of Transcranial Motor-Evoked Potential Linked Quadripolar Montage.
Biomechanical comparison of triangular osteosynthesis and triangular minimally invasive spinopelvic stabilization technique for pelvic fragility fractures.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo